Form 4 Tracker
Arthur F Ryan

Director · 4 filings · Latest: May 1, 2026

REGENERON PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
REGN
Arthur F RyanDirectorMay 1, 2026
Sale
$705.24100$70.5K17,503
REGN
Arthur F RyanDirectorApr 1, 2026
Sale
$777.27100$77.7K17,603
REGN
Arthur F RyanDirectorMar 2, 2026
Sale
$785.50100$78.5K17,703
REGN
Arthur F RyanDirectorFeb 9, 2026
Sale
$778.53100$77.9K17,803
REGN
Arthur F. RyanFeb 9, 2026
Proposed Sale
$785.51400$314.2K